Rachel Klemovitch, Assistant Editor01.17.24
restor3d finalized its announced acquisition of Conformis on September 5, 2023. With the merger completed, these is greater opportunity to deliver cost-effective and clinically differentiated solutions throughout the orthopedic industry.
“We are thrilled to announce the successful achievement of one of our key initiatives post- acquisition. Patient-specific femoral implants, which have traditionally been cast at low margin, are now 3-D printed at a fraction of the cost at our facility in Durham, NC,” restor3d CEO Kurt Jacobus told the press.
This previously cleared additive manufacturing process showcases both companies’ strengths in their respective portfolios in 3D printed biomaterials across the orthopedic landscape including shoulder, spine, foot and ankle, and large joints. This process for producing femoral implants has been successfully commercialized and is outperforming the mechanical properties of cast implants.
“Total knee replacement in entering an era of personalization. Nowhere is this more important than implant design and I believe this is a critical element of achieving the better outcomes that today’s patients expect,” said board certified orthopedic surgeon, Dr. Moby Parsons at Portsmouth Regional Hospital. “restor3d’s printed patient-specific femurs take personalization to the next level of innovation in knee replacement using form and fit to help achieve a more normal feeling. I owe it to my patients to provide the best outcome possible in every case, and this technology is a key solution to that goal.”
“We are thrilled to announce the successful achievement of one of our key initiatives post- acquisition. Patient-specific femoral implants, which have traditionally been cast at low margin, are now 3-D printed at a fraction of the cost at our facility in Durham, NC,” restor3d CEO Kurt Jacobus told the press.
This previously cleared additive manufacturing process showcases both companies’ strengths in their respective portfolios in 3D printed biomaterials across the orthopedic landscape including shoulder, spine, foot and ankle, and large joints. This process for producing femoral implants has been successfully commercialized and is outperforming the mechanical properties of cast implants.
“Total knee replacement in entering an era of personalization. Nowhere is this more important than implant design and I believe this is a critical element of achieving the better outcomes that today’s patients expect,” said board certified orthopedic surgeon, Dr. Moby Parsons at Portsmouth Regional Hospital. “restor3d’s printed patient-specific femurs take personalization to the next level of innovation in knee replacement using form and fit to help achieve a more normal feeling. I owe it to my patients to provide the best outcome possible in every case, and this technology is a key solution to that goal.”